John Stuart Crawford
8Patents
4h-index
3Co-inventors
50Inventor score
Filing activity: Oct 7, 1981 → Dec 16, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4380239A | Intubation of lacrimal ducts | Human Necessities | 20 | Expired |
| US8558055B2 | Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory disease | Human Necessities | 12 | Active |
| US8722964B2 | Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes | Chemistry; Metallurgy | 11 | Active |
| US9314005B2 | Genetically modified rat models for severe combined immunodeficiency (SCID) | Chemistry; Metallurgy | 6 | Active |
| US11089765B2 | Genetically modified rat models for severe combined immunodeficiency (SCID) | Chemistry; Metallurgy | 2 | Active |
| US11849709B2 | Genetically modified rat models for severe combined immunodeficiency (SCID) | Chemistry; Metallurgy | 0 | Active |
| US12274247B2 | Genetically modified rat models for severe combined immunodeficiency (SCID) | Chemistry; Metallurgy | 0 | Active |
| US10131634B2 | Method of treating pain | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.